| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.08 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.08 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.28 | 0.09 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.09 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.09 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.085 | 0.1 |